Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Alzheimer’s disease is one of the most common aging-related neurodegenerative disorders, accounting for more than 60% of dementia cases among the elderly across the globe. While AD is classically diagnosed postmortem based on finding of hallmark brain lesions including amyloid plaques and neurofibrillary tangles, significant advances have been made in the past several decades for early/antemortem diagnosis of Alzheimer’s disease.
The current special issue of JBR Journal of Clinical Diagnosis & Research aims to promote/update the understanding of clinical diagnosis of Alzheimer’s disease. This issue will publish original studies, reviews, case reports or other types of scientific work (e.g., meta-analysis) related but not entirely limited to the following topics: development and application of novel brain imaging technologies, cerebrospinal fluid/peripheral biomarkers and cognitive assessment battery for Alzheimer’s disease /dementia diagnosis; genetic and biochemical assessment of Alzheimer’s disease/dementia risk factors among populations; animal and human studies on neuropathology and disease biology of Alzheimer’s disease/dementia; and current status and challenges on understanding the etiological and pathogenic mechanism of Alzheimer’s disease.
The Journal follows a stringent double blind peer review process for all submitted manuscripts. We welcome manuscripts for the special issue till “March 25th, 2018”. The submitted manuscripts would be published by “April 15th, 2018. As the submission for the special issue would be limited in number & would be processed on a First come First Serve basis. On special Consideration the basic Publication fee would be $919. This may slightly vary based on the extensive editing, colored effects, complex equations, extra elongation of no. of pages of the article, etc
You may submit the manuscript online via https://www.editorialmanager.com/cell-mol-biol/ OR as an e-mail attachment to [email protected]